BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28132100)

  • 1. Towards a systematic nationwide screening strategy for MODY.
    Shields B; Colclough K
    Diabetologia; 2017 Apr; 60(4):609-612. PubMed ID: 28132100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes.
    McDonald TJ; Colclough K; Brown R; Shields B; Shepherd M; Bingley P; Williams A; Hattersley AT; Ellard S
    Diabet Med; 2011 Sep; 28(9):1028-33. PubMed ID: 21395678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study.
    Carlsson A; Shepherd M; Ellard S; Weedon M; Lernmark Å; Forsander G; Colclough K; Brahimi Q; Valtonen-Andre C; Ivarsson SA; Elding Larsson H; Samuelsson U; Örtqvist E; Groop L; Ludvigsson J; Marcus C; Hattersley AT
    Diabetes Care; 2020 Jan; 43(1):82-89. PubMed ID: 31704690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity-onset diabetes of the young? The case of autoimmunity-associated destruction of pancreatic β-cells in a family of HNF1A-MODY subjects.
    Urbanová J; Rypáčková B; Kučera P; Anděl M; Heneberg P
    Int Arch Allergy Immunol; 2013; 161(3):279-84. PubMed ID: 23548576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new screening strategy and whole-exome sequencing for the early diagnosis of maturity-onset diabetes of the young.
    Liu Y; Xie Z; Sun X; Wang Y; Xiao Y; Luo S; Huang G; Li X; Xia Y; Zhou Z
    Diabetes Metab Res Rev; 2021 Jul; 37(5):e3381. PubMed ID: 32621647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register.
    Harsunen M; Kettunen JLT; Härkönen T; Dwivedi O; Lehtovirta M; Vähäsalo P; Veijola R; Ilonen J; Miettinen PJ; Knip M; Tuomi T
    Diabetologia; 2023 Mar; 66(3):438-449. PubMed ID: 36418577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Humoral response markers in GCK MODY].
    Skała-Zamorowska E; Deja G; Borowiec M; Fendler W; Małachowska B; Kamińska H; Wyka K; Młynarski W; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2016; 22(3):. PubMed ID: 28633158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients.
    Shields BM; Shepherd M; Hudson M; McDonald TJ; Colclough K; Peters J; Knight B; Hyde C; Ellard S; Pearson ER; Hattersley AT;
    Diabetes Care; 2017 Aug; 40(8):1017-1025. PubMed ID: 28701371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maturity onset diabetes of the young (MODY) - screening, diagnostic and therapy].
    Kaser S; Resl M
    Wien Klin Wochenschr; 2016 Apr; 128 Suppl 2():S204-7. PubMed ID: 27052244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of candidate gene variants of monogenic diabetes using targeted panel sequencing in early onset diabetes patients.
    Lee DH; Kwak SH; Park HS; Ku EJ; Jeon HJ; Oh TK
    BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 34135026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes.
    Molven A; Ringdal M; Nordbø AM; Raeder H; Støy J; Lipkind GM; Steiner DF; Philipson LH; Bergmann I; Aarskog D; Undlien DE; Joner G; Søvik O; ; Bell GI; Njølstad PR
    Diabetes; 2008 Apr; 57(4):1131-5. PubMed ID: 18192540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to the Patient with MODY-Monogenic Diabetes.
    Broome DT; Pantalone KM; Kashyap SR; Philipson LH
    J Clin Endocrinol Metab; 2021 Jan; 106(1):237-250. PubMed ID: 33034350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Frequencies of Autoimmunity-Associated PTPN22 Polymorphisms in MODY Patients, Including Those Transiently Expressing Islet Cell Autoantibodies.
    Heneberg P; Malá M; Yorifuji T; Gat-Yablonski G; Lebenthal Y; Tajima T; Nogaroto V; Rypáčková B; Kocková L; Urbanová J; Anděl M
    Int Arch Allergy Immunol; 2015; 166(3):189-98. PubMed ID: 25896041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monogenic form of diabetes mellitus due to HNF4α mutation (MODY-1) - the first case in Hungary].
    Jermendy G; Balogh I; Gaál Z
    Orv Hetil; 2016 Mar; 157(12):469-73. PubMed ID: 26971647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two siblings with a rare type of maturity-onset diabetes of the young (MODY).
    Alhakim FR; AlKhayyat H
    BMJ Case Rep; 2023 Feb; 16(2):. PubMed ID: 36764736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes.
    Shepherd M; Shields B; Hammersley S; Hudson M; McDonald TJ; Colclough K; Oram RA; Knight B; Hyde C; Cox J; Mallam K; Moudiotis C; Smith R; Fraser B; Robertson S; Greene S; Ellard S; Pearson ER; Hattersley AT;
    Diabetes Care; 2016 Nov; 39(11):1879-1888. PubMed ID: 27271189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
    Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic genetic testing for recessively inherited monogenic diabetes: a cross-sectional study in paediatric diabetes clinics.
    Patel KA; Ozbek MN; Yildiz M; Guran T; Kocyigit C; Acar S; Siklar Z; Atar M; Colclough K; Houghton J; Johnson MB; Ellard S; Flanagan SE; Cizmecioglu F; Berberoglu M; Demir K; Catli G; Bas S; Akcay T; Demirbilek H; Weedon MN; Hattersley AT
    Diabetologia; 2022 Feb; 65(2):336-342. PubMed ID: 34686905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The broad clinical phenotype of Type 1 diabetes at presentation.
    Merger SR; Leslie RD; Boehm BO
    Diabet Med; 2013 Feb; 30(2):170-8. PubMed ID: 23075321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Confirmation Rate in Clinically Suspected Maturity-Onset Diabetes of the Young.
    Brahm AJ; Wang G; Wang J; McIntyre AD; Cao H; Ban MR; Hegele RA
    Can J Diabetes; 2016 Dec; 40(6):555-560. PubMed ID: 27634015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.